Skip to content

MapLight Therapeutics, Inc.

MPLT· NasdaqCore metricsCIK 1770069

Pharmaceutical preparations552 peers

Last sale
Oct 30, 2026 · -1.94%
Market cap
$422.53M
55.67M shares
Filings
216
—
—
—
-$51.62M
Q3 2026N/M FY25 yoy
-$55.34M
Q3 2026N/M FY25 yoy
-$131.78M
Q3 2026derivedN/M FY25 yoy
-$0.97
Q3 2026N/M FY25 yoy
$55.57M
Q3 2026+22.2% FY25 yoy
$422.53M
—
—
0.9×
-32.80%
—

FY2025 figures · derived

Price

$7.5954.14%$8.96past year
Oct 30, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$138.35MFY 2025
$138.35M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$138,349,000reported
FY 20242024-12-31$68,523,000reported

Pharmaceutical preparations

MapLight Therapeutics, Inc. is the 211th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MapLight Therapeutics, Inc. · CIK 1770069 · Engraved from SEC EDGAR